News

AddToAny

Google+ Facebook Twitter Twitter

IBMS responds to Dame Sally's report

The IBMS has issued a response to Professor Dame Sally Davies’ annual report, which calls on the government to develop genomic medicine’s role in the NHS.

Sarah May, IBMS Deputy Chief Executive, commented on Dame Sally’s focus on genomic testing.

“We support the Chief Medical Officer’s view that DNA testing should become standard across cancer care,” she said. 

“The UK has a workforce of highly skilled and trained biomedical scientists that are preparing to meet this new diagnostic and treatment challenge.” 

She added that the IBMS is launching two new molecular pathology qualifications in 2017. 

These are “intended to directly support the new and expanding science and technology and help to achieve Dame Sally’s vision for personalised diagnosis and healthcare”.

Related Articles

$32M FOR AI DRUGS DISCOVERY START-UP

A Silicon Valley AI and genomics start-up has netted $32m in its first round of funding.

Predicting HIV transmission

Computer simulations can accurately predict the transmission of HIV across populations, say US scientist.

In Vitro Fertilisation Egg Injected with Sperm Science photo

An unusual pregnancy

Yvonne Webb, a Specialist Biomedical Scientist from NHS Greater Glasgow and Clyde, looks back over a case study.

FROM SPECIMEN TO SAFE DNA/RNA IN A SINGLE STEP

MWE recently launched its revolutionary new product Sigma MM Molecular Medium, which renders pathogenic material safe within seconds by killing any bacteria and viruses, while preserving intact DNA and RNA ready for molecular analysis.

Top